DC

Douglas Cubbin

Cyclopharm Limited | Non-Executive Chairman, Non-Executive Director
Mr Cubbin is experienced in nuclear medicine and radiopharmaceutical commercialisation, with a career spanning the full value chain from isotope production through to FDA approval and US market entry. He was Group CFO and a Board Director of Telix Pharmaceuticals through its IPO and the commercialisation of its first FDA-approved product, and prior to that served as Executive Chairman of ANSTO Nuclear Medicine. More recently, he has served as Chairman of both Cyclotek and Oncosil Medical, bringing current and ASX-listed board experience in nuclear medicine and theragnostics.

Company and Roles

Company
Title
Tenure
Since
CYC
CYC
Cyclopharm Limited
  • Non-Executive Chairman
  • Non-Executive Director
2mthMay 2026

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
CYC
CYC
Cyclopharm Limited
04/05/260N/AN/AN/A
OSL
OSL
30/06/2562,000N/A56,250N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
OSL
OSL
13/12/24
Issued
10,000,000$0.007$70,000Placement
OSL
OSL
13/12/24
Issued
10,000,000$0.010$100,000Placement
OSL
OSL
20/05/24
Issued
15,000,000$0.005$75,000Placement
OSL
OSL
20/05/24
Issued
22,500,000$0.005$112,500Placement
OSL
OSL
19/12/23
Issued
5,000,000$0.007$35,000Issue of options